ArticleFrontiers in medicine2026
Challenges in radiopharmaceutical importation across six Southern African Development Community countries: an exploratory study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Radiopharmaceuticals are the backbone of nuclear medicine, essential for accurate diagnosis and effective treatment of various diseases, particularly cancer. Yet across the African region, patients still face delays in nuclear medicine services because radiopharmaceuticals are not available when needed. Due to radionuclide short half-lives, supply delays compromise their effectiveness because of rapid radioactive decay. Aim: This study aimed to investigate, in six English-speaking South African Development Community (SADC) countries, factors that affect radiopharmaceutical importation, identify similarities and differences in their importation processes, determine the customs handling procedure, and identify areas for potential improvement in their importation. Method: The study was an exploratory pilot study. An online questionnaire SurveyMonkey® was distributed to healthcare professionals and distributors with experience in radiopharmaceutical importation in the six target countries via email. Results: Based on 10 completed and two partially completed surveys. The preliminary results suggest that importation costs, frequent logistical delays due to limited transport options, inconsistent customs clearance procedures, and a limited number of suppliers negatively affect access to radiopharmaceuticals in the region. These factors collectively disrupt timely delivery and compromise the availability of nuclear medicine services. Discussion: The importation of radiopharmaceuticals between individual SADC member states is hindered by high import costs, unharmonized customs regulations, limited production capacity, and inefficient transport systems. South Africa remains the main regional supplier, yet its market dominance and high costs restrict access for neighboring countries. Strengthening regional collaboration, harmonizing customs procedures, and expanding local production capacity are essential to improve the accessibility and sustainability of radiopharmaceuticals in the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.